Summary & Overview
HCPCS Level II C2596: Image-Guided Robotic Waterjet Ablation Probe
HCPCS Level II code C2596 designates a probe used for image-guided, robotic waterjet ablation. This equipment-specific code captures supply components integral to robotic, image-directed ablative procedures that use high-pressure waterjet technology to remove or debulk targeted tissue. Nationally, device and supply codes such as C2596 matter because they affect hospital and ambulatory surgical center billing, device tracking, and payer coverage determinations for emerging minimally invasive therapies.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for robotic waterjet ablation, common sites of service where the probe is used, and the typical procedural setting. The publication also summarizes payer coverage patterns and benchmark considerations for device-supply coding, highlights policy developments affecting HCPCS Level II device codes, and outlines reporting best practices relevant to billing and claims adjudication.
This analysis provides clarity on the role of C2596 in procedure coding, the types of clinical procedures that typically use the probe, and the implications for facility billing workflows and payer interactions. Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Billing Code Overview
HCPCS Level II code C2596 describes a probe used for image-guided, robotic waterjet ablation. The item is a single-use or reusable surgical probe component designed to deliver a focused waterjet stream under robotic control, with integrated imaging guidance to target tissue for ablation.
Service Type: Image-guided robotic waterjet ablation procedure
Typical Site of Service: Hospital outpatient department or ambulatory surgical center, where robotic-assisted image-guided ablative procedures are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old male with symptomatic benign prostatic hyperplasia (BPH) refractory to medical therapy who presents for image-guided, robotic waterjet ablation of prostatic tissue. The urology clinic documents lower urinary tract symptoms (weak stream, nocturia, incomplete emptying) and objective findings including enlarged prostate on digital rectal exam and ultrasound with retention episodes. Pre-procedure workflow includes urology consultation, informed consent, preoperative labs (CBC, BMP), urinalysis and urine culture, medication reconciliation including anticoagulation management, and perioperative anesthesia evaluation for monitored anesthesia care or general anesthesia.
On the day of service the patient undergoes transrectal or transperineal ultrasound and MRI fusion as needed for image guidance. The robotic system positions a C2596 probe; the waterjet ablation device is advanced into targeted zones of the prostate under real-time imaging. Saline jet energy is delivered to ablate hyperplastic tissue while preserving surrounding structures. Intraoperative monitoring includes fluoroscopy or ultrasound imaging, hemodynamic monitoring, and urinary catheter placement post-ablation for bladder drainage. Post-procedure recovery includes observation for urinary retention, hematuria, infection prevention counseling, and short-term alpha-blocker therapy as indicated. Follow-up visits at 2 weeks and 3 months assess symptom improvement, urinary flow, and post-void residual volumes.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|